-
Something wrong with this record ?
Sugar-modified derivatives of cytostatic 6-(het)aryl-7-deazapurine nucleosides: 2′-C-methylribonucleosides, arabinonucleosides and 2′-deoxy-2′-fluoroarabinonucleosides
Petr Nauš, Pavla Perlíková, Radek Pohl and Michal Hocek
Language English Country Czech Republic Media elektronický zdroj
NLK
ProQuest Central
from 2005-01-01 to 2011
- MeSH
- Cytostatic Agents MeSH
- Chemistry, Clinical MeSH
- Nucleosides MeSH
- Purines MeSH
- Pyrimidines MeSH
- Structure-Activity Relationship MeSH
A series of novel sugar-modified derivatives of cytostatic 6-hetaryl-7-deazapurine ribonucleosides: 2′-C-methylribonucleosides, arabinonucleosides and 2′-deoxy-2′-fluoroarabinonucleosides bearing an alkyl, aryl and hetaryl group in position 6 were prepared by palladium catalyzed cross-coupling reactions of corresponding (protected) 6-chloro-(7-fluoro)-7-deazapurine nucleosides with (het)arylboronic, hetarylstannanes and trimethylaluminium eventually followed by deprotection. Key intermediate 6-chloro-7-deazapurine 2′-C-methyl-β-D-ribofuranoside was prepared via a stereoselective nucleobase anion glycosylation with toluoyl-protected 1,2-anhydro-2-C-methylribofuranose. The 1,2-anhydro sugar was synthesized in 3 steps starting from readily available 2-C-methylribonolactone. The 6-chloro-7-deazapurine arabinofuranoside intermediate was obtained by epimerization from 3′,5′-protected 6-chloro-7-deazapurine ribofuranoside via 2′-hydroxyl oxidation followed by reduction. None of the prepared compounds showed any considerable cytostatic or antiviral activity.
Sugar-modified derivatives of cytostatic 6-(het)aryl-7-deazapurine nucleosides: 2′-C-methylribonucleosides, arabinonucleosides and 2′-deoxy-2′-fluoroarabinonucleosides [elektronický zdroj] /
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022624
- 003
- CZ-PrNML
- 005
- 20130409235427.0
- 007
- cr|cn|
- 008
- 120806s2011 xr f 000 0eng||
- 009
- eAR
- 024 7_
- $2 doi $a 10.1135/cccc2011082
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Nauš, Petr, $d 1974- $7 xx0124746 $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Gilead Sciences & IOCB Research Center, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
- 245 10
- $a Sugar-modified derivatives of cytostatic 6-(het)aryl-7-deazapurine nucleosides: 2′-C-methylribonucleosides, arabinonucleosides and 2′-deoxy-2′-fluoroarabinonucleosides $h [elektronický zdroj] / $c Petr Nauš, Pavla Perlíková, Radek Pohl and Michal Hocek
- 504 __
- $a Literatura $b 4
- 520 9_
- $a A series of novel sugar-modified derivatives of cytostatic 6-hetaryl-7-deazapurine ribonucleosides: 2′-C-methylribonucleosides, arabinonucleosides and 2′-deoxy-2′-fluoroarabinonucleosides bearing an alkyl, aryl and hetaryl group in position 6 were prepared by palladium catalyzed cross-coupling reactions of corresponding (protected) 6-chloro-(7-fluoro)-7-deazapurine nucleosides with (het)arylboronic, hetarylstannanes and trimethylaluminium eventually followed by deprotection. Key intermediate 6-chloro-7-deazapurine 2′-C-methyl-β-D-ribofuranoside was prepared via a stereoselective nucleobase anion glycosylation with toluoyl-protected 1,2-anhydro-2-C-methylribofuranose. The 1,2-anhydro sugar was synthesized in 3 steps starting from readily available 2-C-methylribonolactone. The 6-chloro-7-deazapurine arabinofuranoside intermediate was obtained by epimerization from 3′,5′-protected 6-chloro-7-deazapurine ribofuranoside via 2′-hydroxyl oxidation followed by reduction. None of the prepared compounds showed any considerable cytostatic or antiviral activity.
- 650 _2
- $a nukleosidy $7 D009705
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a puriny $7 D011687
- 650 _2
- $a pyrimidiny $7 D011743
- 650 _2
- $a cytostatické látky $7 D054697
- 650 _2
- $a klinická chemie $7 D002624
- 700 1_
- $a Perlíková, Pavla, $d 1984- $7 jx20090727020 $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Gilead Sciences & IOCB Research Center, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
- 700 1_
- $a Pohl, Radek $7 xx0086091 $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Gilead Sciences & IOCB Research Center, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
- 700 1_
- $a Hocek, Michal, $d 1969- $7 mzk2006368321 $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Gilead Sciences & IOCB Research Center, Flemingovo nám. 2, 166 10 Prague 6, Czech Republic
- 773 0_
- $t Collection of Czechoslovak chemical communications $x 0010-0765 $g Roč. 76, č. 8 (2011), s. 957-988 $w MED00010973
- 910 __
- $a ABA008 $b A 1006 $c 394 $y 2
- 990 __
- $a 20120806113235 $b ABA008
- 991 __
- $a 20130409235653 $b ABA008
- 999 __
- $a ok $b bmc $g 944537 $s 779922
- BAS __
- $a 3 $a 4
- BMC __
- $a 2011 $b 76 $c 8 $d 957-988 $i 0010-0765 $m Collection of Czechoslovak Chemical Communications $n Collect. Czechoslov. Chem. Commun. (Print) $x MED00010973
- LZP __
- $a 2012-35/dkjs